Rekombinanter VWF Antikörper (AA 2050-2150)
Kurzübersicht für Rekombinanter VWF Antikörper (AA 2050-2150) (ABIN6945293)
Target
Alle VWF Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2050-2150
-
Verwendungszweck
- VWF Recombinant Antibody
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Human Von Willebrand Factor aa 2050-2150
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(WB(1:500-2000)), IHC-P(IHC-P(1:800-2000)), IHC-F(IHC-F(1:800-2000)), IF(IHC-P)(IF(IHC-P)(1:800-2000))
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- VWF (Von Willebrand Factor (VWF))
-
Andere Bezeichnung
- Von Willebrand Factor
-
Hintergrund
-
Synonyms: von Willebrand factor, vWF
Background: Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.
-
Gen-ID
- 7450
-
UniProt
- P04275
Target
-